BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
CAT Acquiring Canadian Firm Focused On Royalties For £55M
Jan. 23, 2002
By
Nuala Moran
Trigen Raises $10M, Looks To Take Drug Into Phase IIb Trials
Jan. 23, 2002
By
Nuala Moran
CXR Spun Out With £4M To Develop Products From Dundee
Jan. 23, 2002
By
Nuala Moran
CXR Spun Out With £4M To Develop Products From Dundee
Jan. 23, 2002
By
Nuala Moran
CAT Acquiring Canadian Firm Focused On Royalties For £55M
Jan. 23, 2002
By
Nuala Moran
Trigen Raises $10M, Looks To Take Drug Into Phase IIb Trials
Jan. 23, 2002
By
Nuala Moran
UK Group Calls For Safeguards Before DNA Database Creation
Jan. 16, 2002
By
Nuala Moran
Protesters Force Stephens Group To Sell Position In Huntingdon
Jan. 16, 2002
By
Nuala Moran
UK Group Calls For Safeguards Before DNA Database Creation
Jan. 16, 2002
By
Nuala Moran
Protesters Force Stephens Group To Sell Position In Huntingdon
Jan. 16, 2002
By
Nuala Moran
Previous
1
2
…
513
514
515
516
517
518
519
520
521
…
530
531
Next